N-(4-naphthalen-1-ylphenyl)-11-phenyl-N-(6-phenylcyclohexa-1,5-dien-1-yl)benzo[a]carbazol-8-amine
C50H36N2 — CID 175613280
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(4-naphthalen-1-ylphenyl)-11-phenyl-N-(6-phenylcyclohexa-1,5-dien-1-yl)benzo[a]carbazol-8-amine
N-(4-naphthalen-1-ylphenyl)-11-phenyl-N-(6-phenylcyclohexa-1,5-dien-1-yl)benzo[a]carbazol-8-amine (PubChem CID 175613280) has the molecular formula C50H36N2 and a molecular weight of 664.85 g/mol. Its IUPAC name is N-(4-naphthalen-1-ylphenyl)-11-phenyl-N-(6-phenylcyclohexa-1,5-dien-1-yl)benzo[a]carbazol-8-amine.
Molecular Properties
| Compound Name | N-(4-naphthalen-1-ylphenyl)-11-phenyl-N-(6-phenylcyclohexa-1,5-dien-1-yl)benzo[a]carbazol-8-amine |
|---|---|
| PubChem CID | 175613280 |
| Molecular Formula | C50H36N2 |
| Molecular Weight | 664.85 g/mol |
| Exact Mass | 664.29 |
| IUPAC Name | N-(4-naphthalen-1-ylphenyl)-11-phenyl-N-(6-phenylcyclohexa-1,5-dien-1-yl)benzo[a]carbazol-8-amine |
| SMILES | C1=C(c2ccccc2)C(N(c2ccc(-c3cccc4ccccc34)cc2)c2ccc3c(c2)c2ccc4ccccc4c2n3-c2ccccc2)=CCC1 |
| InChI | InChI=1S/C50H36N2/c1-3-14-36(15-4-1)44-22-11-12-25-48(44)51(40-29-26-38(27-30-40)43-24-13-18-35-16-7-9-21-42(35)43)41-31-33-49-47(34-41)46-32-28-37-17-8-10-23-45(37)50(46)52(49)39-19-5-2-6-20-39/h1-10,13-34H,11-12H2 |
| InChIKey | DXZCBLWQAKTMHJ-UHFFFAOYSA-N |
| XLogP | 13.66 |
| TPSA | 8.17 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 52 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 664.85 |
| LogP ≤ 5 | 13.66 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175613280 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.